financetom
Business
financetom
/
Business
/
SoFi Techs Unusual Options Activity For October 21
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SoFi Techs Unusual Options Activity For October 21
Oct 21, 2024 7:32 PM

Whales with a lot of money to spend have taken a noticeably bullish stance on SoFi Techs.

Looking at options history for SoFi Techs we detected 21 trades.

If we consider the specifics of each trade, it is accurate to state that 66% of the investors opened trades with bullish expectations and 19% with bearish.

From the overall spotted trades, 7 are puts, for a total amount of $305,952 and 14, calls, for a total amount of $1,152,939.

Projected Price Targets

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $5.0 to $20.0 for SoFi Techs over the last 3 months.

Insights into Volume & Open Interest

In today's trading context, the average open interest for options of SoFi Techs stands at 21652.88, with a total volume reaching 19,471.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in SoFi Techs, situated within the strike price corridor from $5.0 to $20.0, throughout the last 30 days.

SoFi Techs 30-Day Option Volume & Interest Snapshot

Noteworthy Options Activity:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
SOFI CALL SWEEP BULLISH 01/16/26 $6.05 $5.95 $6.05 $5.00 $302.2K 19.1K 1.1K
SOFI CALL SWEEP BULLISH 01/16/26 $6.0 $5.95 $6.0 $5.00 $191.4K 19.1K 2.2K
SOFI CALL TRADE BULLISH 01/17/25 $3.55 $3.5 $3.54 $7.00 $177.0K 51.1K 584
SOFI PUT SWEEP BULLISH 01/17/25 $0.96 $0.94 $0.94 $10.00 $94.7K 18.4K 2.1K
SOFI CALL SWEEP BULLISH 01/16/26 $6.0 $5.95 $6.0 $5.00 $91.2K 19.1K 2.7K

About SoFi Techs

SoFi is a financial-services company that was founded in 2011 and is based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020, the company also offers payment and account services for debit cards and digital banking.

Following our analysis of the options activities associated with SoFi Techs, we pivot to a closer look at the company's own performance.

Present Market Standing of SoFi Techs

With a trading volume of 19,115,091, the price of SOFI is up by 1.42%, reaching $10.32.

Current RSI values indicate that the stock is may be overbought.

Next earnings report is scheduled for 8 days from now.

Turn $1000 into $1270 in just 20 days?

20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for SoFi Techs with Benzinga Pro for real-time alerts.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Novo Nordisk Obesity Drug Achieves Up to 22% Weight Loss in Clinical Trial
Novo Nordisk Obesity Drug Achieves Up to 22% Weight Loss in Clinical Trial
Jan 24, 2025
11:16 AM EST, 01/24/2025 (MT Newswires) -- Novo Nordisk's ( NVO ) said Friday that its investigative weight loss drug, amycretin, led to a body weight reduction of up to 22% in an early-stage trial. The maker of obesity drug Wegovy and diabetes treatment Ozempic said its phase 1b/2a trial covered 125 overweight people. The trial involved three different once-weekly...
Union Pacific Delivered 'Comfortable' Q4 Headline Beat But Remains 'Show-Me Story' in the Near Term, Morgan Stanley Says
Union Pacific Delivered 'Comfortable' Q4 Headline Beat But Remains 'Show-Me Story' in the Near Term, Morgan Stanley Says
Jan 24, 2025
11:17 AM EST, 01/24/2025 (MT Newswires) -- Union Pacific ( UNP ) delivered a decent headline beat with its Q4 results helped by one time-ish cost items, Morgan Stanley said in a note to clients emailed Friday. The railroad company also provided somewhat vague guidance, the investment firm said, adding that Union Pacific ( UNP ), like its peers in...
Texas Instruments' Gross Margin Performance to Trail Peers, Morgan Stanley Says
Texas Instruments' Gross Margin Performance to Trail Peers, Morgan Stanley Says
Jan 24, 2025
11:18 AM EST, 01/24/2025 (MT Newswires) -- Texas Instruments' ( TXN ) gross margins are expected to lag behind industry peers until 2026, while free cash flow benefits are seen somewhat overstated, Morgan Stanley said Friday in a note. The company's gross margins have declined significantly, from above 70% to the mid-50% range, the firm said, following the release of...
Blockmate Investee Hivello Enters AI Partnership with AIxBlock
Blockmate Investee Hivello Enters AI Partnership with AIxBlock
Jan 24, 2025
11:18 AM EST, 01/24/2025 (MT Newswires) -- Blockmate Ventures ( MATEF ) said Friday its investee Hivello Holdings partnered with artificial intelligence development platform AIxBlock to integrate decentralized computing power into AI applications. AIxBlock offers a comprehensive development platform to build, train and deploy AI models that typically have high computing power requirements to function optimally, Blockmate ( MATEF )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved